top of page
logo 4 b copy.jpg
The Studio at Kendall Square

About the show:  The Studio at Kendall Square is a video podcast studio built by BiotechTV and MassBio at MassBio's headquarters in Tech Square at Kendall Square. It is a platform for the Boston biotech community to use and have your podcast discussions recorded in-person and then broadcast on BiotechTV. The studio will give voice to the vast network of experts who live in and around 'The Most Innovative Square Mile on the Planet'. If you have an idea for a discussion that you would like to host, please apply to participate. Details and email address in the left sidebar under “How to Participate."

How to Participate

If you have an idea for a discussion you would like to host that will be recorded at The Studio and broadcast on BiotechTV, please email us at ksq (at) biotechtv (dot com) and let us know your name and affiliation, your potential guest's name and affiliation, and the topic of the discussion. Discussion ideas should be educational and non-promotional about your company or institution. Topics could be things such as: recent news analysis, discussions about key technologies or other research in development, discussions of newsworthy scientific papers that have recently been published, patient perspectives, conference previews, regulatory issues, company creation, and more. Your creativity is welcome regarding what the BiotechTV audience might like to watch. Note: All ideas are appreciated, but not all will be accepted...we will get back to you with feedback about your request and, if accepted, details about scheduling. Thank you!

Episodes

Precision for Medicine CMO Harpreet Singh and Repertoire Immune Medicines CMO Robert Andtbacka discuss oncology clinical trial design, life on the biotech side, and advice for other CMOs | 09/05/25
Two leaders from the Harvard Biotech Club talk about their experience in the club, its new podcast, The Pulse, and an upcoming career fair on September 19th | 09/02/25
MassBio's CEO Kendalle Burlin O'Connell shares the details of today's just published 2025 Industry Snapshot - a key barometer of the health of biotech not just in Massachusetts, but as an industry | 08/26/25
Two experts in genetic medicines, Devan Shah and Michelle Lynn Hall, discuss the recently announced federal funding cuts for mRNA research and what it means for this area of science going forward | 08/18/25
Lisa Deschamps of AviadoBio and Richard Wilson of Astellas discuss the current state of AAV gene therapy, and their partnership on AVB-101, an AAV gene therapy for frontotemporal dementia (FTD) | 06/18/25
Biotech veteran Art Krieg explains the science behind his newest immunotherapy company, Zola Therapeutics, which uses both RNA and DNA agonists delivered in an LNP to create broad T-cell responses | 04/22/25
Elias Zerhouni and Andy Plump discuss the future of multispecific biologics | 04/07/25
Candel Therapeutics CEO Paul Peter Tak and IDEA Pharma CEO Mike Rea on why they believe a different mindset and good communication are keys to succeeding with new innovations in biotech | 04/01/25
Korro Bio's Ram Aiyar and Novo Nordisk's Uli Stilz discuss their RNA editing collaboration, the field of genetic medicine, and the future of drug discovery | 03/05/25
Devan Shah and Namita Bisaria, experts in the field of RNA therapies, discuss the year ahead in RNA - opportunities, challenges, AI, fundraising, and more | 02/24/25
The co-founder of the Scientific Citizenship Initiative discusses the importance of scientific communication, and trying to place STEM PhDs into the Mass. State House as full-time policy advisors | 01/22/25
A patient advocacy group founded by two parents has partnered with biotech company on a gene therapy for limb-girdle muscular dystrophy Type 2C/R5 - it was just cleared to start a clinical trial | 11/20/24
Janssen's Elena Diez and Odyssey Therapeutics' Gary Glick share advice on success factors for pharma - biotech partnership relationships, and more | 11/14/24
Kojin Therapeutics Chairman & CEO Harvey Berger shares an update on the company's progress and talks about the funding environment for earlier stage companies in biotech | 10/25/24
Transcriptional regulation in disease, opportunities, challenges, and the future | 10/24/24
A father and patient advocate discusses Canavan disease and his daughter's experience on a gene therapy clinical trial | 10/23/24
Gene therapy experts TJ Cradick and Andrew Kernytsky discuss the issues surrounding unintended off-target editing of genetic tools like CRISPR 10/17/24
professor_george_church_on_founder_led_companies,_technologies_of_today,_the_future,_and_more (720p)
Gene therapy experts TJ Cradick and Kate Excoffon discuss using AAV gene therapy for cystic fibrosis | 10/03/24
Immuno-Oncology experts Zhen Su and Kristen Hege discuss the latest in the field and preview #SITC24 | 10/01/24

Be a part of The Studio

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

evaluate-logo-png_seeklogo-457165-2_edited.png

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

bottom of page